Search Within

Neuroblastoma Service

Formats
  1. Journal Article (515)
  2. Meeting Abstract (295)
  3. Review (18)
  4. Book Section (14)
  5. Conference Paper (14)
  6. Editorial (5)
  7. Correspondence (2)
  8. Book Whole (1)
  9. Guidelines (1)
Groups
  1. Pediatrics, Department of (865)
  2. GSK Faculty (687)
  3. Tow Center for Developmental Oncology (TCDO) (682)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (674)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (655)
  6. Center for Hematologic Malignancies (225)

More Groups

People
  1. Nai-Kong Cheung (653)
  2. Brian Kushner (313)
  3. Shakeel Modak (251)
  4. Kim Kramer (178)
  5. Steven Larson (111)
  6. Stephen Roberts (107)

More People

Years
  1. 2025 (17)
  2. 2024 (26)
  3. 2023 (36)
  4. 2022 (44)
  5. 2021 (41)
  6. 2020 (49)

More Years

Publications
  1. Pediatric Blood and Cancer (116)
  2. Journal of Clinical Oncology (98)
  3. Cancer Research (41)
  4. Journal of Nuclear Medicine (36)
  5. Neuro-Oncology (32)
  6. Clinical Cancer Research (27)

More Publications

Publishers
  1. Wiley Periodicals, Inc (120)
  2. American Association for Cancer Research (102)
  3. American Society of Clinical Oncology (101)
  4. Elsevier Inc. (55)
  5. Oxford University Press (42)
  6. Nature Publishing Group (36)

More Publishers

Results (865)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data
    Meeting Abstract

    Mora, J.; Chan, G.; Morgenstern, D.; Nysom, K.; Bear, M.; Dalby, L. W.; Lisby, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Reactive regional lymphadenopathy associated with neuroblastoma immunotherapy
    Meeting Abstract

    Lentini-Rivera, A.; Kushner, B.; Modak, S.; Price, A.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Updated entrectinib data from a phase 1/2 trial in children and adolescents with recurrent or refractory solid tumors, including primary central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Robinson, G. W.; Basu, E. M.; Foster, J.; Gauvain, K.; Sabnis, A. J.; Macy, M. E.; Maese, L.; Yoon, J.; Cash, T.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Surveillance for early detection of neuroblastoma central nervous system relapse
    Meeting Abstract

    Modak, S.; Kushner, B.; Cheung, N. K.; Kramer, K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Telemedicine blood pressure monitoring after anti-GD2 monoclonal antibody immunotherapy during the COVID-19 pandemic
    Meeting Abstract

    Glincher, R.; Cheung, N. K.; Kasper, C.; Scoppetuolo, L. A.; Modak, S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Favorable toxicity profile of bivalent GD2/GD3 neuroblastoma vaccine
    Meeting Abstract

    Modak, S.; Cheung, N. K.; Basu, E.; Roberts, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • COVID-19 in pediatric hematology and oncology patients in New York City
    Meeting Abstract

    Gampel, B.; Troullioud Lucas, A.; Broglie, L.; Gartrell-Corrado, R.; Lee, M.; Levine, J.; Orjuela-Grimm, M.; Satwani, P.; Glade Bender, J.; Roberts, S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors
    Meeting Abstract

    Miyachi, M.; Desai, A.; Robinson, G.; Basu, E.; Foster, J.; Gauvain, K.; Sabnis, A.; Gajjar, A.; STARTRK-NG study group
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
    Journal Article

    Park, J. A.; Cheung, N. K. V.
    Journal of Hematology & Oncology (2020)

    Fulltext@MSK | Save